DM199 for Pregnancy Complications

NCT06875141•DiaMedica Therapeutics Inc

Summary

This entry was submitted in error by DiaMedica Therapeutics, Inc. and was not authorized by any of the trial Investigators or study sponsor (Stellenbosch University). The clinical trial, DM199 for Pregnancy Complications, was prospectively registered with the Pan African Clinical Trials Registry (PACTR202404895013782), in accordance with ICMJE and WHO requirements. This listing serves as the primary and authoritative registration record for this investigator-initiated study.

Eligibility

Age

18 - 50 years

Sex

FEMALE

Healthy Volunteers

Inclusion Criteria

•Please refer to the Pan African Clinical Trials Registry (PACTR202404895013782).

Key Dates

Start Date

May 1, 2025

Primary Completion Date

May 1, 2025

Completion Date

May 1, 2025

Last Updated

June 4, 2025

Conditions

Pre-Eclampsia

Interventions

DM199

BIOLOGICAL

APPLE: Aspirin to Prevent Pregnancy Loss and Preeclampsia

NCT06408181

Pre-EclampsiaPregnancy Loss

View study

RECRUITINGPHASE1

Autologous Decidual-like Natural Killer Cells Therapy for Infertility or Adverse Pregnancy History

NCT06821685

Abortion, HabitualInfertility Unexplained+2 more

View study

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: June 4, 2025Data synced to Clareo: March 29, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions

DM199 for Pregnancy Complications

Inclusion Criteria

APPLE: Aspirin to Prevent Pregnancy Loss and Preeclampsia

Autologous Decidual-like Natural Killer Cells Therapy for Infertility or Adverse Pregnancy History

Vascular Biomarkers Predictive of the Progression From Hypertensive Disorders in Pregnancy to Preeclampsia in Pregnant Women

Optic Nerve Sheath Measurement and Angiogenic Factors in Patients With Pre-eclampsia.

Bioimpedence and Arterial Function Monitoring at Birth and in Infants

Wearables to Define Postpartum Blood Pressure Trajectories and Facilitate Evidence-based Monitoring Guidelines